JP2015536326A5 - - Google Patents

Download PDF

Info

Publication number
JP2015536326A5
JP2015536326A5 JP2015538056A JP2015538056A JP2015536326A5 JP 2015536326 A5 JP2015536326 A5 JP 2015536326A5 JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015538056 A JP2015538056 A JP 2015538056A JP 2015536326 A5 JP2015536326 A5 JP 2015536326A5
Authority
JP
Japan
Prior art keywords
amdac
individual
effective amount
therapeutically effective
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015538056A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015536326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/065653 external-priority patent/WO2014063035A2/en
Publication of JP2015536326A publication Critical patent/JP2015536326A/ja
Publication of JP2015536326A5 publication Critical patent/JP2015536326A5/ja
Pending legal-status Critical Current

Links

JP2015538056A 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療 Pending JP2015536326A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261716091P 2012-10-19 2012-10-19
US61/716,091 2012-10-19
US201361783752P 2013-03-14 2013-03-14
US61/783,752 2013-03-14
PCT/US2013/065653 WO2014063035A2 (en) 2012-10-19 2013-10-18 Treatment of pain using amnion derived adherent cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018132024A Division JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療

Publications (2)

Publication Number Publication Date
JP2015536326A JP2015536326A (ja) 2015-12-21
JP2015536326A5 true JP2015536326A5 (enExample) 2016-12-08

Family

ID=50488901

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015538056A Pending JP2015536326A (ja) 2012-10-19 2013-10-18 羊膜由来接着細胞を利用する疼痛の治療
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018132024A Pending JP2018188456A (ja) 2012-10-19 2018-07-12 羊膜由来接着細胞を利用する疼痛の治療
JP2020104367A Withdrawn JP2020180128A (ja) 2012-10-19 2020-06-17 羊膜由来接着細胞を利用する疼痛の治療
JP2022091267A Active JP7315755B2 (ja) 2012-10-19 2022-06-06 羊膜由来接着細胞を利用する疼痛の治療

Country Status (6)

Country Link
US (1) US20160166618A1 (enExample)
EP (1) EP2909314B1 (enExample)
JP (4) JP2015536326A (enExample)
CA (1) CA2888772A1 (enExample)
DK (1) DK2909314T3 (enExample)
WO (1) WO2014063035A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016006270A (es) 2013-11-15 2016-09-07 Anthrogenesis Corp Composiciones que comprenden células perfundidas de placenta humana, subpoblaciones de las mismas y sus usos.
CN113679741B (zh) * 2021-09-13 2023-09-19 北京大学第一医院 人羊膜上皮干细胞在制备治疗顺铂诱导的急性肾损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210379B1 (en) 1999-04-16 2007-03-21 Wm. MARSH RICE UNIVERSITY Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
ES2420354T3 (es) * 2000-07-07 2013-08-23 Spectrum Pharmaceuticals, Inc. Métodos para el tratamiento de neuropatía periférica inducida por una enfermedad y afecciones relacionadas
NZ527849A (en) 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
DK2471904T3 (en) 2005-12-29 2019-02-18 Celularity Inc Placenta stem cell populations
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
CA2743566C (en) * 2008-11-19 2021-11-09 Anthrogenesis Corporation Amnion derived adherent cells
AU2010322808B9 (en) * 2009-11-30 2014-08-07 Pluri Biotech Ltd Adherent cells from placenta and use of same in disease treatment
KR20140022776A (ko) * 2010-11-16 2014-02-25 지우세페 마리네오 아편제 및 통상적인 전기 진통에 내성이 있는 신경병증 통증, 종양 통증 및 소아 통증을 신속히 억제하기 위한 장치 및 방법
AU2011343736A1 (en) * 2010-12-17 2013-05-02 Anthrogenesis Corporation Treatment of immune-related diseases and disorders using amnion derived adherent cells
AR084753A1 (es) 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)

Similar Documents

Publication Publication Date Title
IL239923A0 (en) Solid solution compositions and use in cardiovascular disease
SI3594348T1 (sl) Sestavki kratko aktivirajoče rna c/ebp alfa in postopki uporabe
PH12014502481A1 (en) Use of pro-fungicides of uk-2a for control of black sigatoka
DK2996701T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose
GB2562396A (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
JP2012500090A5 (enExample)
CL2013000238A1 (es) Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
EP3043819A4 (en) Anti-vstm5 antibodies and the use thereof in therapy and diagnosis
IL234508B (en) Inhalation of nitric oxide for treating respiratory diseases
PH12015500114B1 (en) HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF
WO2015004609A3 (en) Adherent cells from placenta and use thereof in treatment of injured tendons
PL2612551T3 (pl) Kompozycja roztoczy zawierająca roztocza drapieżnego i unieruchomiony żer w kontakcie ze środkiem ograniczającym grzyby oraz sposoby i zastosowania dotyczące stosowania wspomnianej kompozycji
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
IL272308A (en) Use of inhaled nitric oxide for the improvement of right and/or left ventricular function
PL2793929T3 (pl) Podłoże kondycjonowane uzyskane z łożyskowych mezenchymalnych komórek macierzystych w terapii stanu przedrzucawkowego
WO2015066197A3 (en) Cardiac neural crest cells and methods of use thereof
EP2951286A4 (en) RECOMBINANT MICROORGANISMS WITH NADPH-DEPENDENT ENZYMES AND METHOD FOR THE PRODUCTION THEREOF
EP2702142A4 (en) METHOD FOR THE USE OF BIOLOGICAL ACTIVE SUBSTANCES WITH LIVING OR RESTING FORMS OF BACTERIA AND OTHER ORGANISMS IN THE TREATMENT OF INFECTIONS, INFLAMMATORY DISEASES AND OTHER DISORDERS OF THE DISTAL THIN DRAIN AND THICK DARM
JP2014530176A5 (enExample)
HK1206984A1 (en) Combination therapy of anti-mif antibodies and glucocorticoids
JP2015536326A5 (enExample)
JP2014526564A5 (enExample)
HK1194912A2 (en) Growth factor concentrate and the use thereof
WO2016071770A3 (en) Biological markers for identifying ibrutinib resistance in patients having mantle cell lymphoma and methods of using the same
PL3027208T3 (pl) Diagnoza i terapia nowotworu z udziałem nowotworowych komórek macierzystych